Quarterly report · Q2
2112.TEDINET S100PGCP
Period2022-04-01 → 2022-09-30
Filed2022-11-04
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥13.4bn | 2022-04-01 → 2022-09-30 | Cons. | Net sales |
| Revenue | ¥25.1bn | 2021-04-01 → 2022-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥12.2bn | 2021-04-01 → 2021-09-30 | Cons. | Net sales |
| Operating income | ¥274m | 2022-04-01 → 2022-09-30 | Cons. | Operating income |
| Operating income | ¥454m | 2021-04-01 → 2021-09-30 | Cons. | Operating income |
| Ordinary income | ¥244m | 2022-04-01 → 2022-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥906m | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥389m | 2021-04-01 → 2021-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥244m | 2022-04-01 → 2022-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥389m | 2021-04-01 → 2021-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥138m | 2022-04-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥609m | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥233m | 2021-04-01 → 2021-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥138m | 2022-04-01 → 2022-09-30 | Cons. | Profit loss |
| Net income | ¥233m | 2021-04-01 → 2021-09-30 | Cons. | Profit loss |
| Total assets | ¥25.2bn | at 2022-09-30 | Cons. | Assets |
| Total assets | ¥26.1bn | at 2022-03-31 | Cons. | Assets |
| Total assets | ¥26.7bn | at 2021-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥14.8bn | at 2022-09-30 | Cons. | Liabilities |
| Total liabilities | ¥15.7bn | at 2022-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥10.4bn | at 2022-09-30 | Cons. | Net assets |
| Net assets / equity | ¥10.4bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥10.0bn | at 2021-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥2.3bn | at 2022-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥3.5bn | at 2022-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥2.3bn | at 2022-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥3.5bn | at 2022-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥3.7bn | at 2021-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥4.9bn | at 2021-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥104m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.1bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥210m | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥172m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥711m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥482m | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥1.2bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥1.7bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥948m | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥5.1 | 2022-04-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-3.14 | 2022-07-01 → 2022-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥22.43 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥8.61 | 2021-04-01 → 2021-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-1.55 | 2021-07-01 → 2021-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 41.2% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 39.7% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 37.5% | at 2021-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 38
| Segment | Item | Period | Value |
|---|---|---|---|
| Otherother segments | revenue | 2022-04-01 → 2022-09-30 | ¥67m |
| Otherother segments | revenue external | 2022-04-01 → 2022-09-30 | ¥59m |
| Otherother segments | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥8m |
| Otherother segments | segment profit | 2022-04-01 → 2022-09-30 | ¥30m |
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-09-30 | −¥55m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2022-09-30 | −¥55m |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-09-30 | −¥577m |
| jpcrp040300-q2r_E00361-000Biotechnologyreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥925m |
| jpcrp040300-q2r_E00361-000Biotechnologyreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥891m |
| jpcrp040300-q2r_E00361-000Biotechnologyreportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥34m |
| jpcrp040300-q2r_E00361-000Biotechnologyreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥238m |
| jpcrp040300-q2r_E00361-000Sugarreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥12.4bn |
| jpcrp040300-q2r_E00361-000Sugarreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥12.4bn |
| jpcrp040300-q2r_E00361-000Sugarreportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥13m |
| jpcrp040300-q2r_E00361-000Sugarreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥582m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2022-09-30 | ¥13.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2022-09-30 | ¥13.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥55m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2022-09-30 | ¥851m |
| Otherother segments | revenue | 2021-04-01 → 2021-09-30 | ¥66m |
| Otherother segments | revenue external | 2021-04-01 → 2021-09-30 | ¥58m |
| Otherother segments | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥8m |
| Otherother segments | segment profit | 2021-04-01 → 2021-09-30 | ¥30m |
| Reconciling Itemsreconciling | revenue | 2021-04-01 → 2021-09-30 | −¥50m |
| Reconciling Itemsreconciling | revenue intersegment | 2021-04-01 → 2021-09-30 | −¥50m |
| Reconciling Itemsreconciling | segment profit | 2021-04-01 → 2021-09-30 | −¥586m |
| jpcrp040300-q2r_E00361-000Biotechnologyreportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥939m |
| jpcrp040300-q2r_E00361-000Biotechnologyreportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥910m |
| jpcrp040300-q2r_E00361-000Biotechnologyreportable segment | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥28m |
| jpcrp040300-q2r_E00361-000Biotechnologyreportable segment | segment profit | 2021-04-01 → 2021-09-30 | ¥264m |
| jpcrp040300-q2r_E00361-000Sugarreportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥11.3bn |
| jpcrp040300-q2r_E00361-000Sugarreportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥11.3bn |
| jpcrp040300-q2r_E00361-000Sugarreportable segment | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥14m |
| jpcrp040300-q2r_E00361-000Sugarreportable segment | segment profit | 2021-04-01 → 2021-09-30 | ¥745m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-04-01 → 2021-09-30 | ¥12.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-04-01 → 2021-09-30 | ¥12.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥50m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-04-01 → 2021-09-30 | ¥1.0bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 493
| Item | Context | Value | Unit |
|---|---|---|---|
| Independent auditors report consolidated (text) | FilingDateInstant | Text · Plus | |
| Audit firm1 consolidated | FilingDateInstant | Original text (Japanese)監査法人日本橋事務所 | |
| Cpa1 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)吉 岡 智 浩 | |
| Cpa2 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)小 倉 明 | |
| Number of submission | FilingDateInstant | 1 | |
| Net sales (5-year summary) | Prior1YTDDuration | 12246000000 | JPY |
| Net sales (5-year summary) | CurrentYTDDuration | 13384000000 | JPY |
| Net sales (5-year summary) | Prior1YearDuration | 25134000000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YTDDuration | 389000000 | JPY |
| Ordinary income loss (5-year summary) | CurrentYTDDuration | 244000000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YearDuration | 906000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YTDDuration | 233000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | CurrentYTDDuration | 138000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YearDuration | 609000000 | JPY |
| Comprehensive income (5-year summary) | Prior1YTDDuration | 239000000 | JPY |
| Comprehensive income (5-year summary) | CurrentYTDDuration | 122000000 | JPY |
| Comprehensive income (5-year summary) | Prior1YearDuration | 576000000 | JPY |
| Net assets (5-year summary) | Prior1QuarterInstant | 10041000000 | JPY |
| Net assets (5-year summary) | CurrentQuarterInstant | 10381000000 | JPY |
| Net assets (5-year summary) | Prior1YearInstant | 10379000000 | JPY |
| Total assets (5-year summary) | Prior1QuarterInstant | 26745000000 | JPY |
| Total assets (5-year summary) | CurrentQuarterInstant | 25202000000 | JPY |
| Total assets (5-year summary) | Prior1YearInstant | 26114000000 | JPY |
| Basic earnings loss per share (5-year summary) | Prior1YTDDuration | 8.61 | |
| Basic earnings loss per share (5-year summary) | CurrentYTDDuration | 5.10 | |
| Basic earnings loss per share (5-year summary) | Prior1YearDuration | 22.43 | |
| Diluted earnings per share (5-year summary) | Prior1YTDDuration | － | |
| Diluted earnings per share (5-year summary) | CurrentYTDDuration | － | |
| Diluted earnings per share (5-year summary) | Prior1YearDuration | － | |
| Equity to asset ratio (5-year summary) | Prior1QuarterInstant | 0.375 | |
| Equity to asset ratio (5-year summary) | CurrentQuarterInstant | 0.412 | |
| Equity to asset ratio (5-year summary) | Prior1YearInstant | 0.397 | |
| Net cash provided by used in operating activities (5-year summary) | Prior1YTDDuration | 210000000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | CurrentYTDDuration | 104000000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | Prior1YearDuration | 1082000000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior1YTDDuration | -482000000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | CurrentYTDDuration | -172000000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior1YearDuration | -711000000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior1YTDDuration | -948000000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | CurrentYTDDuration | -1175000000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior1YearDuration | -1738000000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior1QuarterInstant | 3677000000 | JPY |
| Cash and cash equivalents (5-year summary) | CurrentQuarterInstant | 2300000000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior1YearInstant | 3533000000 | JPY |
| Basic earnings loss per share (5-year summary) | Prior1QuarterDuration | -1.55 | |
| Basic earnings loss per share (5-year summary) | CurrentQuarterDuration | -3.14 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 35000000 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 35000000 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 35000000 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 35000000 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |